T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Pool Corp
POOL
$7.29B
| $113M | 0.02% |
1,999,189
-692,140
| -26% | -$40.4M |
|
|
MDCO
602
DELISTED
Medicines Co
MDCO
| $113M | 0.02% |
3,882,025
-1,715,270
| -31% | -$45.8M |
|
|
MDSO
603
DELISTED
Medidata Solutions, Inc.
MDSO
| $112M | 0.02% |
2,621,400
+1,916,100
| +272% | +$79.6M |
|
604
TIM SA
TIMB
$8.27B
| $112M | 0.02% |
3,852,805
-1,138,320
| -23% | -$31.1M |
|
605
Telephone and Data Systems
TDS
$4.03B
| $112M | 0.02% |
4,280,444
-474,000
| -10% | -$12.6M |
|
606
Encompass Health
EHC
$12.2B
| $111M | 0.02% |
3,902,416
+22,249
| +0.6% | +$620K |
|
|
XLRN
607
DELISTED
Acceleron Pharma
XLRN
| $111M | 0.02% |
3,271,727
+1,427,884
| +77% | +$47.7M |
|
608
Progress Software
PRGS
$1.83B
| $111M | 0.02% |
4,616,870
-4,460
| -0.1% | -$97.3K |
|
609
Matador Resources
MTDR
$6.39B
| $110M | 0.02% |
3,762,582
-63,442
| -2% | -$1.68M |
|
610
Jack Henry & Associates
JKHY
$11.1B
| $110M | 0.02% |
1,852,692
-70,865
| -4% | -$4.04M |
|
|
ECOL
611
DELISTED
US Ecology, Inc.
ECOL
| $110M | 0.02% |
2,245,197
+698,257
| +45% | +$32.1M |
|
612
Ally Financial
ALLY
$13.6B
| $108M | 0.02% |
+4,634,600
| New | +$113M |
|
613
Red Robin
RRGB
$183M
| $108M | 0.02% |
1,517,221
-3,030
| -0.2% | -$212K |
|
|
MLNX
614
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $107M | 0.02% |
3,075,447
-266,080
| -8% | -$9.22M |
|
|
ALOG
615
DELISTED
Analogic Corp
ALOG
| $107M | 0.02% |
1,367,852
-226,030
| -14% | -$17.2M |
|
|
ANN
616
DELISTED
ANN INC
ANN
| $107M | 0.02% |
2,592,835
-24,060
| -0.9% | -$960K |
|
|
JCP
617
DELISTED
J.C. Penney Company, Inc.
JCP
| $106M | 0.02% |
11,767,096
+5,101,786
| +77% | +$44M |
|
618
Dolby
DLB
$5.84B
| $106M | 0.02% |
2,462,164
-566,400
| -19% | -$23.7M |
|
|
SCU
619
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
| $106M | 0.02% |
767,771
+15,030
| +2% | +$1.93M |
|
620
Compass Minerals
CMP
$1.1B
| $106M | 0.02% |
1,103,306
-247,790
| -18% | -$22.3M |
|
621
Helios Technologies
HLIO
$2.67B
| $105M | 0.02% |
2,581,540
+12,700
| +0.5% | +$504K |
|
622
TD Synnex
SNX
$20.4B
| $105M | 0.02% |
2,876,820
-6,700
| -0.2% | -$225K |
|
623
HP
HPQ
$28.6B
| $104M | 0.02% |
6,804,590
+108,493
| +2% | +$1.63M |
|
624
Constellation Brands
STZ
$23.3B
| $104M | 0.02% |
1,177,485
-255,144
| -18% | -$21.1M |
|
|
MHFI
625
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $104M | 0.02% |
1,249,171
-840,303
| -40% | -$66.2M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.